Imidin N Nasentropfen,

Xylometazoline Hydrochloride, the active ingredient in Imidin N Nasentropfen, is a alpha‑adrenergic agonist presented as a nasal drops for nasal use. It relieves nasal congestion associated with the common cold, sinusitis and allergic rhinitis in both adults and children.\n\nGNH India supplies Imidin N Nasentropfen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Xylometazoline Hydrochloride is an alpha‑adrenergic agonist used to alleviate nasal congestion in upper‑respiratory conditions.\n\nCommon cold: reduces nasal blockage and improves airflow.\nSinusitis: alleviates mucosal swelling to ease breathing.\nAllergic rhinitis: diminishes congestion caused by allergen exposure.

Adverse reactions may occur with the use of Xylometazoline Hydrochloride nasal drops.\n\nCommon Side Effects:\n- Nasal irritation: mild burning or stinging sensation.\n- Dryness of nasal mucosa.\n- Sneezing: transient increase after application.\n- Headache: mild and temporary.\n\nSerious or Rare Side Effects:\n- Rebound congestion (rhinitis medicamentosa): prolonged use may cause worsening blockage.\n- Severe hypertension: rare systemic absorption leading to elevated blood pressure.

When using Imidin N Nasentropfen, consider the following precautions.\n\nAge restriction: not recommended for children under 6 years without medical advice.\nDuration of use: limit to 3‑5 days to avoid rebound congestion.\nPregnancy and lactation: consult a healthcare professional before use.\nExisting cardiovascular disease: use with caution due to possible systemic vasoconstriction.\nDrug interactions: avoid concurrent use with monoamine oxidase inhibitors.\nStore at room temperature: keep in the original container, protect from moisture and direct sunlight.

Xylometazoline Hydrochloride may interact with other medicines.\n\nMajor Interactions (Avoid):\n- MAO inhibitors: risk of hypertensive crisis.\n- Other nasal decongestants: additive vasoconstriction may cause severe hypertension.\n\nModerate Interactions (Monitor Closely):\n- Beta‑blockers: may blunt systemic vasoconstrictive response.\n- Antihypertensive agents: monitor blood pressure regularly.\n- Tricyclic antidepressants: possible additive cardiovascular effects.